Technical Analysis for REVB - Revelation Biosciences, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bullish Signal Line Cross | Bullish | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 8.60% | |
| Stochastic Buy Signal | Bullish | 8.60% | |
| Outside Day | Range Expansion | 8.60% | |
| Wide Bands | Range Expansion | 8.60% | |
| Gapped Up | Strength | 8.60% | |
| Oversold Stochastic | Weakness | 8.60% | |
| Oversold Stochastic | Weakness | 3.59% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | 1 day ago |
| Rose Above Previous Day's High | 1 day ago |
| 10 DMA Resistance | 1 day ago |
| Up 5% | 1 day ago |
| Up 10% | 1 day ago |
Free Daily (Stock) Chart Reading
- Earnings date: 05/20/2024
Revelation Biosciences, Inc. Description
Revelation Biosciences, Inc. is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. Revelation has several product candidates in development. REVTx-99, the lead therapeutic candidate, is an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses such as SARS-CoV-2, including its variants, influenza A and B, parainfluenza, rhinovirus, and RSV. REVTx-99 is also being developed for other indications such as: allergic rhinitis and chronic nasal congestion. REVTx-200 is an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. REVTx-200 is based on the same technology used in REVTx-99. In addition to Revelation’s therapeutic pipeline, Revelation is also developing REVDx-501, a rapid home use diagnostic that can be used to detect any respiratory viral infection, regardless of virus type or strain, without the need for specialized instrumentation.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Clinical Medicine Disease Immunology Infection Vaccination Respiratory Diseases Allergology Nasal Administration Rhinitis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 39.0 |
| 52 Week Low | 1.7801 |
| Average Volume | 75,591 |
| 200-Day Moving Average | 12.64 |
| 50-Day Moving Average | 2.34 |
| 20-Day Moving Average | 2.12 |
| 10-Day Moving Average | 2.07 |
| Average True Range | 0.22 |
| RSI (14) | 43.18 |
| ADX | 10.3 |
| +DI | 20.88 |
| -DI | 21.31 |
| Chandelier Exit (Long, 3 ATRs) | 1.83 |
| Chandelier Exit (Short, 3 ATRs) | 2.45 |
| Upper Bollinger Bands | 2.44 |
| Lower Bollinger Band | 1.79 |
| Percent B (%b) | 0.35 |
| BandWidth | 30.79 |
| MACD Line | -0.14 |
| MACD Signal Line | -0.15 |
| MACD Histogram | 0.0011 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.41 | ||||
| Resistance 3 (R3) | 2.39 | 2.24 | 2.35 | ||
| Resistance 2 (R2) | 2.24 | 2.14 | 2.25 | 2.32 | |
| Resistance 1 (R1) | 2.13 | 2.08 | 2.19 | 2.15 | 2.30 |
| Pivot Point | 1.98 | 1.98 | 2.01 | 1.99 | 1.98 |
| Support 1 (S1) | 1.87 | 1.88 | 1.93 | 1.89 | 1.74 |
| Support 2 (S2) | 1.72 | 1.82 | 1.73 | 1.72 | |
| Support 3 (S3) | 1.61 | 1.72 | 1.70 | ||
| Support 4 (S4) | 1.63 |
